Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled time : 14:00 save search
Ljósleiðarinn's CFO Resigns from Position
Published: 2024-04-22 (Crawled : 14:00) - globenewswire.com
XYF | News | $3.815 -1.74% 0.39% 5.4K
|
Finance
|
| O: 1.85%
H: 0.0%
C: 0.0%
LinkShadow is positioned as a Representative Vendor in the 2024 Gartner® Market Guide for Network Detection and Response (NDR)
Published: 2024-04-18 (Crawled : 14:00) - prnewswire.com
IT | $451.06 0.18% 0.0% 280K
|
Commercial Services
|
| O: -0.15%
H: 0.0%
C: 0.0%
gartner for network response market
Vallen Distribution Announces Key Executive Leadership Positions
Published: 2024-04-11 (Crawled : 14:00) - prnewswire.com
WCC F | $159.59 0.27% 0.0% 430K
|
Distribution Services
|
| O: -0.62%
H: 0.0%
C: 0.0%
distribution key
Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
MBRX | $4.6 3.37% 7.4K
|
Health Technology
|
| O: 5.18%
H: 0.0%
C: -12.5%
mb-106 positive aml trial
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
ATXS | $9.02 -6.43% -6.87% 660K
|
Manufacturing
|
| O: 10.71%
H: 0.9%
C: -11.94%
star-0215 positive trial therapeutics results
FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
HUGE | News | $0.4634 -5.24% -5.52% 280K
|
Process Industries
|
| O: -13.48%
H: 15.52%
C: 12.05%
pharma positive sclerosis treatment research results lucid-21-302 study
Ensysce Biosciences Receives Positive Nasdaq Listing Determination - February 27, 2024
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
ENSC | $0.5583 1.58% 43K
|
Health Technology
|
| O: 2.12%
H: 0.02%
C: -2.19%
nasdaq positive
AGBA Group is Positioned For Hong Kong's Rebounding Macro Environment with Business Refinements and Growth Strategies
Published: 2024-02-27 (Crawled : 14:00) - globenewswire.com
AGBA | $2.4 -19.19% -23.75% 21M
|
Finance
|
| O: 5.49%
H: 0.0%
C: -11.46%
business group growth
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
Published: 2024-02-06 (Crawled : 14:00) - globenewswire.com
GOVX | $1.54 1.27% 35K
|
Health Technology
|
| O: 2.77%
H: 2.69%
C: 1.92%
cm04 covid-19 vaccine universal geo-cm04s1 positive trial
Wrap Technologies, Inc. Positions for Scale with Manufacturing and Sales Expansion while Reducing Workforce by 30%
Published: 2024-02-05 (Crawled : 14:00) - globenewswire.com
WRAP | $1.975 -2.23% -2.28% 130K
|
Manufacturing
|
| O: 71.81%
H: 0.0%
C: -43.37%
wrap sales expansion
ARS Pharmaceuticals to Present Positive Clinical Efficacy Data for neffy® (epinephrine nasal spray) at 2024 AAAAI Annual Meeting
Published: 2024-02-05 (Crawled : 14:00) - globenewswire.com
SPRY M | $8.26 -2.82% -2.91% 330K
|
Manufacturing
|
| O: 0.16%
H: 2.2%
C: 0.16%
neffy positive pharmaceuticals meeting
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
Published: 2024-01-24 (Crawled : 14:00) - globenewswire.com
SILO | $1.9 6.74% 6.32% 380K
|
Finance and Insurance
|
| O: 10.0%
H: 5.19%
C: -3.9%
pharma disease alzheimer’s positive results study
OpenText Positioned as a Leader in IDC MarketScape for Multi-Enterprise Supply Chain Commerce Networks
Published: 2024-01-17 (Crawled : 14:00) - prnewswire.com
OTEX | $35.05 0.86% 0.86% 530K
|
Technology Services
|
| O: -0.97%
H: 0.06%
C: -0.03%
networks
S&P Upgrades Phillips Edison & Company’s Rating Outlook to ‘Positive’ from ‘Stable’
Published: 2024-01-11 (Crawled : 14:00) - globenewswire.com
PECO | $33.21 -0.84% -0.84% 450K
|
Finance and Insurance
|
| O: -0.57%
H: 1.25%
C: 1.17%
NeuroSense Recaps Positive 2023 Achievements Including Statistically Significant Slowing of Disease Progression in Phase 2b ALS Trial of PrimeC and Highlights Anticipated 2024 Catalysts
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
NRSN | News | $1.33 -2.21% -2.26% 130K
|
|
| O: 6.36%
H: 3.57%
C: -1.67%
primec disease als positive trial
European Medicines Agency Validates Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer and NTRK-Positive Solid Tumors
Published: 2024-01-02 (Crawled : 14:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.27%
H: 3.89%
C: 2.55%
lung tumors cancer cell treatment application advanced
SELLAS Life Sciences Reports Positive Follow-Up Immune Response and Survival Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo® in Advanced Malignant Pleural Mesothelioma
Published: 2023-12-27 (Crawled : 14:00) - globenewswire.com
SLS | $1.54 -5.52% -5.84% 1.3M
|
Health Technology
|
| O: -2.78%
H: 4.75%
C: 0.0%
opdivo life positive sciences advanced response study
LP and LP Foundation Drive Positive Change in 2023 With $875,000 in Donations
Published: 2023-12-27 (Crawled : 14:00) - prnewswire.com
LPX | $75.19 1.76% 0.0% 970K
|
Non-Energy Minerals
|
| O: -0.03%
H: 1.49%
C: 1.03%
change positive
Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300
Published: 2023-12-22 (Crawled : 14:00) - prnewswire.com
TYRA | $16.02 -2.2% -2.25% 62K
|
Health Technology
|
| O: 1.39%
H: 2.67%
C: -3.03%
tyra-200 first positive tyra-300
La Rosa Acquires Fourth Real Estate Brokerage Franchisee with Revenue of $2.7 Million and Positive Net Income in 2022
Published: 2023-12-20 (Crawled : 14:00) - globenewswire.com
LRHC | $1.57 -2.48% -2.55% 13K
|
n/a
|
| O: 10.26%
H: 2.66%
C: -7.56%
rosa revenue positive
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.